From Our Partners
Tuesday, June 28, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

NIAID Contract to Medigen for Influenza Virus-Like Particles

by Global Biodefense Staff
July 2, 2013

Virus ParticlesThe National Institute of Allergy and Infectious Diseases (NIAID) this week announced intentions to procure laboratory testing services to produce, purify, and quantify viral-like particles (VLPs) from Medigen, Inc. on a sole source basis.

Medigen will provide all the necessary reagents, equipment and personnel with expertise to perform the planned experiments necessary to produce six highly purified influenza VLPs specific to sequences of the influenza plasmids supplied by NIAID.

NIAID states the contractor will produce 1-5mg purified influenza VLPs by performing:

High-titer baculovirus stocks from the six influenza plasma provided by NIAID
Production and harvest six lots of VLPs in serum free medium from SF9 cells
Purification of six VLPS to greater than 80% purity with the techniques to be employed that will be either tangential flow filtration and or affinity chromatography
Quality control assessment of protein content using bicinchoninic acid assays or SDS polyacrylamide gel electrophoresis
Epitope confirmation using western blot and electron microscopy
Hemagglutination assays

The performance period is six months from the date of award. Work will be performed in Bethesda, Maryland.

Source: FBO.gov

From Our Partners
Tags: AwardsInfluenza

Related Posts

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine
Medical Countermeasures

Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine

May 30, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC